Claude AI Raises New Safety Questions as It Autonomously Designs Lab-Validated Protein Binders
7 Articles
7 Articles
Claude AI Raises New Safety Questions as It Autonomously Designs Lab-Validated Protein Binders
Claude AI designed 1,320 protein binders and sent them into an automated lab pipeline, where 354 were confirmed to bind their intended targets, raising fresh questions about how far AI can now go on its own in biological design. The work, led by Adaptyv Bio using Anthropic's Claude models, effectively showed an AI system assembling and running much of a protein-design workflow, with humans and lab robots handling only the physical experiments. T…
Anthropic unveils Claude Academy to boost AI education and adoption
Anthropic's Claude Academy could enhance AI literacy, boost investor confidence, and potentially elevate the company's market valuation. The post Anthropic unveils Claude Academy to boost AI education and adoption appeared first on Crypto Briefing.
Claude Academy Teaches How to Use AI Safely and Effectively
Recent reports show that more non-developers are using AI to create apps and to work more quickly. Coupled with the pace of change within frontier models, the need for workers to understand how to use AI safely and effectively grows in urgency. Anthropic has created within its Claude Academy a 4D AI Fluency Framework that includes four competencies: Delegation, Description, Discernment, and Diligence. Anthropic said it teaches this while onboard…
Anthropic released this week an experiment in which artificial intelligence Claude designed from zero components capable of connecting to biological targets, a fundamental step in the creation of new drugs. The tests achieved a success rate of up to 35.1%, exceeding with ease the usual average of the biotechnology sector, ranging from 10% to 15%. Anthropic conducted scientific research using the Mythos Preview and Opus 4.8 versions of the platfo…
Anthropic triples the conventional success rate in protein design, a breakthrough with direct impact on pharmaceutical R & D. Keys of operation Claude triples the conventional success rate in protein design. Between 22.6% and 35.1% of candidates worked against the usual 10-15% in the industry. Anthropic did not discover a new molecule: it orchestrated existing tools. The model coordinated software for protein design, sequencing and folding alrea…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
